EBF2 Antikörper (AA 53-254)
-
- Target Alle EBF2 Antikörper anzeigen
- EBF2 (Early B-Cell Factor 2 (EBF2))
-
Bindungsspezifität
- AA 53-254
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EBF2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Transcription factor COE2 protein (53-254AA)
- Isotyp
- IgG
-
anti-Early B-Cell Factor 2 (EBF2) antibody
EBF2 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Early B-Cell Factor 2 (EBF2) (AA 405-454) antibodyEBF2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Affe, Schwein, Fledermaus, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Early B-Cell Factor 2 (EBF2) (AA 359-408) antibodyEBF2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Hund, Affe, Schwein, Fledermaus, Huhn, Xenopus laevis WB Wirt: Kaninchen Polyclonal unconjugated
anti-Early B-Cell Factor 2 (EBF2) (AA 285-536) antibodyEBF2 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Early B-Cell Factor 2 (EBF2) (Middle Region) antibodyEBF2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Hund, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- EBF2 (Early B-Cell Factor 2 (EBF2))
- Andere Bezeichnung
- EBF2 (EBF2 Produkte)
- Synonyme
- EBF2 antikoerper, Zcoe2 antikoerper, D14Ggc1e antikoerper, EBF-2 antikoerper, Mmot1 antikoerper, O/E-3 antikoerper, OE-3 antikoerper, EBF-2-A antikoerper, Xcoe-2 antikoerper, Xcoe2 antikoerper, Xebf-2 antikoerper, Xebf-2-A antikoerper, Xebf2 antikoerper, coe2 antikoerper, coe2-a antikoerper, ebf2 antikoerper, oe3 antikoerper, COE2 antikoerper, early B-cell factor 2 antikoerper, early B cell factor 2 antikoerper, early B-cell factor 2 S homeolog antikoerper, EBF2 antikoerper, ebf2 antikoerper, Ebf2 antikoerper, ebf2.S antikoerper
- Hintergrund
-
Background: Transcription factor that, in osteoblasts, activates the decoy receptor for RANKL, TNFRSF11B, which in turn regulates osteoclast differentiation. Acts in synergy with the Wnt-responsive LEF1/CTNNB1 pathway. Recognizes variations of the palindromic sequence 5\\\'-ATTCCCNNGGGAATT-3\\\' (By similarity).
Aliases: EBF2 antibody, COE2Transcription factor COE2 antibody, Early B-cell factor 2 antibody, EBF-2 antibody
- UniProt
- Q9HAK2
-
